Quite a material transaction ($8.2 million) in light of the market cap of ENA currently $21.5 million thereabouts. My first impression is that it must be positive since both Tom Kent, MD, and Tony Leibowitz, Chairman, are both substantial shareholders in ENA, so must consider it positive. Perhaps the macro economy for UK at the moment, especially with issues with political upheaval, outstanding Brexit issues, and European problems with Ukraine/energy make the transaction a safe option.
ENA Price at posting:
23.5¢ Sentiment: Buy Disclosure: Held
